Targeting cancer stem cells with differentiation agents as an alternative to genotoxic chemotherapy for the treatment of malignant testicular germ cell tumors
May 18, 2021 11:00pm ‐ May 18, 2021 11:00pm
Speaker(s):
- Amanda R. Loehr, BS, Cornell University
The role of lncRNA ADAMTS9-AS2 in cancer: a double-edged sword in metastatic progression?
May 18, 2021 11:00pm ‐ May 18, 2021 11:00pm
Speaker(s):
- Angelica B. Boldt, PhD, Universidade Federal do Paraná
Targeting HNF1A-dependent stemness and tumor growth in pancreatic cancer
May 18, 2021 11:00pm ‐ May 18, 2021 11:00pm
Speaker(s):
- Bharani Muppavarapu, MSc, Roswell Park Comprehensive Cancer Center division, University at Buffalo
ALDH proteins as regulators of prostate cancer metastases and radioresistance
May 18, 2021 11:00pm ‐ May 18, 2021 11:00pm
Speaker(s):
- Ielizaveta Gorodetska, PhD, Institute of Radiooncology - OncoRay
Single-cell atlas of tumor clonal evolution in liver cancer
May 18, 2021 11:00pm ‐ May 18, 2021 11:00pm
Speaker(s):
- Lichun Ma, PhD, National Cancer Institute
RNA binding protein DDX5 directs DCLK+ tumor stem cell specification to regulate microbial repertoire and promote tumorigenesis in the intestine
May 18, 2021 11:00pm ‐ May 18, 2021 11:00pm
Speaker(s):
- Wendy Jia Men Huang, PhD, University of California San Diego
C/EBPB-dependent Adaptation to Palmitic Acid Promotes Stemness in Hormone Receptor Negative Breast Cancer
May 18, 2021 11:00pm ‐ May 18, 2021 11:00pm
Speaker(s):
- Xiaozheng Liu, MSc, University of Bergen
Welcoming Remarks
May 19, 2021 7:00am ‐ May 19, 2021 7:10am
Speaker(s):
- Irene Oi Lin Ng, MD, PhD, University of Hong Kong
Stem Cells and Cancer
May 19, 2021 7:00am ‐ May 19, 2021 8:55am
Co-Chair(s):
- Irene Oi Lin Ng, MD, PhD, University of Hong Kong
- Xin Wei Wang, PhD, NCI, National Institutes of Health
Chemical Induction of Pluripotency
May 19, 2021 7:10am ‐ May 19, 2021 7:35am
Speaker(s):
- Duanqing Pei, PhD, Guangzhou Institutes of Biomedicine and Health